Tech Company Financing Transactions
WellDoc Funding Round
Johnson & Johnson Development Corporation and private investors participated in a $7.5 million Series B funding round for WellDoc. This venture round was recorded on 3/2/2016.
Transaction Overview
Company Name
Announced On
3/2/2016
Transaction Type
Venture Equity
Amount
$7,500,000
Round
Series B
Proceeds Purpose
WellDoc plans to work with LifeScan to integrate BlueStar, an FDA-cleared mobile application and program for people with Type II diabetes, with LifeScan's OneTouch Verio Flex Bluetooth Smart blood glucose monitoring system and its companion app, OneTouch Reveal mobile app.
Company Information
Company Status
Private & Independent
Industry
Software
Mailing Address
10221 Wincopin Cir. 150
Columbia, MD 21044
USA
Columbia, MD 21044
USA
Phone
Website
Email Address
Overview
WellDoc Communications is an endocrinologist owned and operated diabetes management company. We are leading the development and implementation of innovative technology solutions for the management of diabetes and revolutionizing the way diabetes is treated to close currently existing quality of care gaps.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Kevin McRaith
Chief Marketing Officer
Tara Charvat
Chief Scientific Officer
Anand Iyer
VP - Operations
Caroline York
Browse more venture capital transactions:
Prev: 3/2/2016: Eight Sleep venture capital transaction
Next: 3/2/2016: Verax Biomedical venture capital transaction
Share this article
About Our Venture Capital Transactions Database
We do our best to report on tech company VC transactions. VC investment data records reported here are sourced from news reports and company announcements. The information comes to us via our partnership with VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs